Global pediatric vaccine market to hit $23B by 2015
The global pediatric vaccine market will likely hit a value of more than $23 billion by 2015, a market analysis shows.
From 2005 to 2011, pediatric vaccines doubled their market share, according to a Renub Research analysis, and will continue to shoot upward. Analysts can attribute much of that growth to blockbuster vaccines such as Pfizer's ($PFE) Prevnar 7 and Prevnar 13, Glaxo's Rotarix and Merck's ($MRK) Rotateq. Pediatric proprietary vaccines will probably lead the vaccine market with just less than 60% market share by 2015, the report says.